Related Experiment Video
Updated: Nov 2, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
REG3A/REG3B promotes acinar to ductal metaplasia through binding to EXTL3 and activating the RAS-RAF-MEK-ERK
Huairong Zhang1,2,3, Andrea Liliam Gomez Corredor2, Julia Messina-Pacheco2
1Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
Persistent acinar to ductal metaplasia (ADM) is a recently recognized precursor of pancreatic ductal adenocarcinoma (PDAC). Here we show that the ADM area of human pancreas tissue adjacent to PDAC expresses significantly higher levels of regenerating protein 3A (REG3A). Exogenous REG3A and its mouse homolog REG3B induce ADM in the 3D culture of primary human and murine acinar cells, respectively. Both Reg3b transgenic mice and REG3B-treated mice with caerulein-induced pancreatitis develop and sustain ADM. Two out of five Reg3b transgenic mice with caerulein-induced pancreatitis show progression from ADM to pancreatic intraepithelial neoplasia (PanIN). Both in vitro and in vivo ADM models demonstrate activation of the RAS-RAF-MEK-ERK signaling pathway. Exostosin-like glycosyltransferase 3 (EXTL3) functions as the receptor for REG3B and mediates the activation of downstream signaling proteins. Our data indicates that REG3A/REG3B promotes persistent ADM through binding to EXTL3 and activating the RAS-RAF-MEK-ERK signaling pathway. Targeting REG3A/REG3B, its receptor EXTL3, or other downstream molecules could interrupt the ADM process and prevent early PDAC carcinogenesis.
Insights
Regenerating protein 3A (REG3A) and its homolog REG3B promote pancreatic acinar-ductal metaplasia (ADM), a precursor to pancreatic cancer. Targeting REG3A/REG3B or its receptor EXTL3 may prevent pancreatic ductal adenocarcinoma (PDAC) development.
Area of Science:
- Oncology
- Gastroenterology
- Cell Biology
Background:
- Persistent acinar-to-ductal metaplasia (ADM) is a recognized precursor to pancreatic ductal adenocarcinoma (PDAC).
- The molecular mechanisms driving persistent ADM remain incompletely understood.
Purpose of the Study:
- To investigate the role of regenerating protein 3A (REG3A) in promoting ADM.
- To elucidate the signaling pathways and molecular targets involved in REG3A-mediated ADM.
Main Methods:
- Analysis of human pancreatic tissue adjacent to PDAC.
- 3D cell culture of human and murine acinar cells treated with REG3A or REG3B.
- In vivo studies using REG3B transgenic mice and caerulein-induced pancreatitis models.
- Investigation of the RAS-RAF-MEK-ERK signaling pathway and EXTL3 receptor function.
Main Results:
- ADM areas in human pancreas tissue adjacent to PDAC show elevated REG3A levels.
- Exogenous REG3A and REG3B induce ADM in vitro and in vivo.
- REG3B promotes ADM progression, with some cases advancing to PanIN in vivo.
- REG3B signals through EXTL3 to activate the RAS-RAF-MEK-ERK pathway.
Conclusions:
- REG3A/REG3B drives persistent ADM by binding to EXTL3 and activating the RAS-RAF-MEK-ERK pathway.
- Targeting REG3A/REG3B, EXTL3, or downstream effectors offers a potential strategy to prevent PDAC initiation.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
The Ras Gene
Ras is a...
Master Transcription Regulators
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

